Bayer AG (FRA:BAYN) received a €126.00 ($141.57) price target from analysts at Commerzbank Ag in a research note issued on Wednesday. The firm currently has a “buy” rating on the healthcare company’s stock.

BAYN has been the subject of several other reports. Deutsche Bank AG set a €120.00 ($134.83) price objective on Bayer AG and gave the stock a “buy” rating in a research report on Thursday, February 23rd. Goldman Sachs Group Inc set a €120.00 ($134.83) price objective on Bayer AG and gave the stock a “buy” rating in a research report on Thursday, February 9th. Independent Research GmbH set a €109.00 ($122.47) price objective on Bayer AG and gave the stock a “neutral” rating in a research report on Friday, February 17th. Jefferies Group LLC set a €125.00 ($140.45) price objective on Bayer AG and gave the stock a “buy” rating in a research report on Wednesday, February 15th. Finally, JPMorgan Chase & Co. reaffirmed a “buy” rating on shares of Bayer AG in a research report on Thursday, February 9th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of €115.71 ($130.02).

Analyst Recommendations for Bayer AG (FRA:BAYN)

Shares of Bayer AG (FRA BAYN) opened at 118.85 on Wednesday. The stock’s 50 day moving average price is €114.78 and its 200-day moving average price is €105.16. Bayer AG has a 1-year low of €85.00 and a 1-year high of €121.97. The stock has a market capitalization of €103.56 billion and a P/E ratio of 19.66.

ILLEGAL ACTIVITY WARNING: This story was first published by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.watchlistnews.com/bayer-ag-bayn-given-a-126-00-price-target-by-commerzbank-ag-analysts/1346966.html.

About Bayer AG

.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with Analyst Ratings Network's FREE daily email newsletter.